It varies. In studies, Tagrisso helped some people with non-small cell lung cancer (NSCLC) live longer than those taking certain other medications. The drug may also help extend amount of time a person lives with the disease before it gets worse.
Several factors can affect a person’s life expectancy with NSCLC. Examples of these factors include how advanced your cancer is, other medical conditions you may have, and how well your body tolerates cancer treatments.
If you have questions about what to expect from Tagrisso treatment, talk with your doctor.